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Abstract
Background
Aedes aegypti is the primary vector of dengue fever, a viral disease which has an estimated
incidence of 390 million infections annually. Conventional vector control methods have
been unable to curb the transmission of the disease. We have previously reported a novel
method of vector control using a tetracycline repressible self-limiting strain of Ae. aegypti
OX513A which has achieved >90% suppression of wild populations.
Methodology/Principal Findings
We investigated the impact of tetracycline and its analogues on the phenotype of OX513A
from the perspective of possible routes and levels of environmental exposure. We determined
the minimum concentration of tetracycline and its analogues that will allow an increased survi-
vorship and found these to be greater than the maximum concentration of tetracyclines found
in known Ae. aegypti breeding sites and their surrounding areas. Furthermore, we determined
that OX513A parents fed tetracycline are unable to pre-load their progeny with sufficient anti-
dote to increase their survivorship. Finally, we studied the changes in concentration of tetracy-
cline in the mass production rearing water of OX513A and the developing insect.
Conclusion/Significance
Together, these studies demonstrate that potential routes of exposure of OX513A individu-
als to tetracycline and its analogues in the environment are not expected to increase the
survivorship of OX513A.
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Author Summary
Dengue fever is spread by the mosquito Aedes aegypti and the most effective method to
limit the spread of dengue is to reduce the mosquito population. We have previously
reported a transgenic strain of Ae. aegypti which results in>90% population suppression:
males, which do not transmit disease, are released into the field carrying a self-limiting
gene to mate with wild females, passing on the self-limiting gene which causes>95% prog-
eny to die before becoming vectors of disease. To be able to breed this mosquito in the lab-
oratory an antidote, tetracycline, is used to suppress the effects of the transgene. Given
that tetracyclines are commonly used in human and veterinary medicine, it is essential to
consider whether sufficient tetracycline could be in the environment to prevent the effec-
tive use of this control method by allowing the female’s progeny (from a mating between a
released OX513A male and a wild female) to survive. Here we have shown that the concen-
trations of tetracycline to which the mosquitoes will be exposed in the environment, both
in breeding sites and in a blood-meal host are not high enough to influence the effective-
ness of this control method.
Introduction
Dengue fever is a viral infection, primarily transmitted by the mosquito Aedes aegypti, with an
estimated incidence of 390 million infections annually [1]. There are currently no licensed vac-
cines [2, 3] so control of the disease is focused on suppression of the vector. Commonly
employed vector control techniques such as larval site removal, use of larvicides and insecticide
fogging have been unable to provide satisfactory control of Ae. aegypti and dengue transmission.
Previously we have reported a novel method of vector control based on the sterile insect
technique (SIT) [4–6]. In this approach, males homozygous for a tetracycline repressible trans-
gene, which confers the self-limiting trait to progeny are released into the environment where
they search for and mate with wild females. Offspring of these males inherit a single copy of
the transgene and, lacking adequate exposure to the tetracycline repressor,>95% die before
becoming adults and potential vectors of blood borne diseases. Using the OX513A strain of Ae.
aegypti, this method resulted in the suppression of the wild Ae. aegypti population in East End,
Grand Cayman [5] and in Itaberaba, Brazil.
To enable the breeding of OX513A individuals in the laboratory, the self-limiting phenotype
of the transgene is repressed by the provision of tetracycline in the larval rearing water. In the
absence of tetracycline, the transcriptional transactivator, tTAV (a synthetic sequence compris-
ing a tetracycline binding domain and transactivator), binds to its DNA binding site, tetO (tet-
racycline operator), to drive high levels of expression of tTAV [4] (Fig 1A). The production of
tTAV results in over expression of this protein via a positive feedback loop; intracellular accu-
mulation of tTAV becomes cytotoxic, eventually leading to the organism´s death [4, 7]. How-
ever, if OX513A larvae are reared in water containing tetracycline at sufficient concentrations,
the tetracycline binds to tTAV causing a conformational change, preventing its binding to tetO
and stopping establishment of the self-limiting positive feedback loop (Fig 1B) [8]. For this sys-
tem to work as intended, the self-limiting phenotype must be sufficiently repressed by tetracy-
cline provided during rearing in contained conditions. Conversely, for field effectiveness, the
self-limiting phenotype must not be substantially repressed by tetracycline at doses found in
the larval habitats of this mosquito. Here we look in detail at the interaction of OX513A with
tetracycline(s) and the impact on phenotype.
Aedes aegyptiOX513A and Tetracycline
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Tetracyclines are a family of broad-spectrum antibiotics. They are well known in human
therapy and, owing to their low cost, are used in animal production as therapeutics, prophylac-
tics and growth promoters, although many countries have banned this use [9, 10]. Agricultural
use in particular can result in significant quantities being excreted, ending up in sewage systems
or in manure [10]. However, although tetracyclines can be adsorbed to certain soils [11], they
are highly susceptible to photolysis and hydrolysis giving some tetracyclines half-lives of only a
few hours, limiting their environmental load [12]. Fortunately, there is considerable interest in
antibiotic load in the environment and numerous surveys have been conducted: for tetracy-
clines these focus primarily on tetracycline, oxytetracycline, chlortetracycline and doxycycline.
A survey of the literature found maximum reported concentrations from field sites around the
world as follows; tetracycline 0.096 ng mL-1 to 1.3 ng mL-1 (e.g. [13–17]) chlortetracycline 0.04
ng mL-1 to 0.97 ng mL-1 [18, 19], oxytetracycline 0.7 ng mL-1 to 1.34 ng mL-1 [20, 21] and
doxycycline 0.07 ng mL-1 to 0.4 ng mL-1 [14, 20].
These data have largely been generated from examination of tetracycline compound levels
in input and output flows from wastewater treatment plants, where they are expected to reach
particularly high concentrations as a result of excretion during therapeutic use, along with the
testing of the efficiency of removal of tetracyclines during the treatment of the wastewater.
However these environments are not typical Ae. aegypti larval habitats which include artificial
containers such as used car tyres, flower vases, water storage vessels and discarded materials in
the domestic and peri-domestic environment. Reports have also been made of Ae. aegypti
breeding in septic tanks [22] and brackish waters [23], especially where covers are broken or
cracked but these are regarded as unusual.
Given that tetracyclines are present in the environment, albeit at low levels, it is important
to understand the possible routes of exposure of OX513A individuals to these tetracyclines and
the impact that such exposure could have on its phenotype, especially on the expression of the
self-limiting trait. We have therefore identified potential routes of exposure of OX513A to envi-
ronmental sources of tetracyclines; these include larval breeding sites and human and veteri-
nary patients, where potential environmental concentrations of tetracyclines have been
explored and have also investigated the impact of such exposure at relevant concentrations on
the phenotype of OX513A.
Methods
Mosquito strains
OX513A is a tetracycline repressible bi-sex lethal strain of Aedes aegypti [24].
Fig 1. Tetracycline-repressible positive feedback loop in OX513A. In the absence of tetracycline (A)
tTAV is expressed and causes mortality. In the presence of tetracycline (TC) (B) tetracycline binds to and
represses the tTAV and allows development to adulthood (adapted from [35]).
doi:10.1371/journal.pntd.0003999.g001
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The wild type (WT) strain used is a non-transgenic version of the genetic background of
OX513A.
Insect rearing
All insects were reared at 27°C [+/- 1°C], 70% [+/- 10%] relative humidity, 12h: 12h light: dark
cycle. Unless stated otherwise, five cohorts of 200 larvae for each treatment were reared at 1
larva mL-1 in 16 oz pots (Robertson Packaging, UK SICC65) and fed a standard regimen of
finely ground Tetramin fish flakes (Tetra GmbH, Germany). Live pupae were counted and
placed into cages (15 cm x 15 cm x 15 cm, Bugdorm-Megaview, Taiwan). Dead larvae and dead
pupae were counted and discarded. Adults were provided with 10% sucrose solution ad libitum.
Adult cages were assessed three days after the last pupa was added. Assessment included count-
ing the total number of dead pupae, non-viable adults (dead adults on the water, dead adults on
the floor of the cage and non-flying adults) and functional adults (flying adults).
Homozygous outcrosses
OX513A homozygous larvae were reared in the presence of 30 μg mL-1 chlortetracycline (the
standard tetracycline supplement used in rearing); WT larvae were reared at a similar density in
the absence of tetracycline. Larvae were fed ad libitum. Unless otherwise stated, OX513Amales
were outcrossed toWT females. Adults were blood fed using defibrinated horse blood (TCS Bio-
sciences Ltd., UK). Heterozygous eggs were collected and used for the following experiments.
Dose response of OX513A to tetracycline and its analogues
An initial tetracycline dose response curve was produced using chlortetracycline hydrochloride
(Sigma-Aldrich, UK). Following this, tetracycline, oxytetracycline and doxycycline were tested
(Sigma-Aldrich, UK). In all of these experiments heterozygous OX513A larvae were reared in
the presence of different concentrations of chlortetracycline, tetracycline, oxytetracycline or
doxycycline. As a control, OX513A were also reared in parallel in the absence of tetracycline or
its analogues. Preliminary experiments were used to establish the appropriate dose range for
each compound. Raw data are presented in S1 Table.
Changes in chlortetracycline concentration during mass rearing
Samples were collected at life stages between eggs and pupae (Fig 2). For each sampling point,
5 repeats of 0.5 g of the relevant mosquito life-stage were collected along with 5 repeats of 1.5
mL of the associated rearing water. To sample L1/L2 larvae (1 day post hatching) OX513A eggs
were hatched and the larvae reared for 24 hours in the absence of tetracycline after which the
larvae and the rearing water samples were collected. For samples of L3, L3/L4 and pupae,
OX513A eggs were hatched and the larvae reared at the mass rearing density of 3 larvae mL-1
in 1 L of water supplemented on day one post hatching with chlortetracycline (Sigma-Aldrich,
UK) to a final concentration of 30 μg mL-1. The samples were stored at -20°C before being
shipped on dry ice to CEM Analytical Services (Bracknell, UK) for analysis.
Samples were analysed in accordance with the Association of Analytical Communities
(AOAC) methodology for analysis of tetracycline in edible animal tissues (AOAC method
995.09) with the modification of LC-MS/MS (liquid chromatography with positive-ion electro-
spray tandemmass spectrometry) for the final quantitation rather than UV, along with a recov-
ery sample. Residues of chlortetracycline were extracted from the specimens by homogenizing
in EDTA solution (pH 4). Two further extractions were combined with the first extract, filtered
and the sample further purified using a C18, solid phase extraction cartridge. After
Aedes aegyptiOX513A and Tetracycline
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conditioning the cartridge, the total volume of extract was percolated through the cartridge.
After washing, the chlortetracycline was eluted using a methanolic oxalic acid solution and the
final extract diluted with water. The samples were analysed by LC-MS/MS, using the transition
479.2> 444.1 amu with a 0.1% formic acid in water/methanol mobile phase and a 250 x 4.6
mm C8, 5 μm column. Raw data are presented in S2 Table.
Fig 2. Dose response of OX513A to tetracycline and its analogues. A) Chlortetracycline dose response. Data shown for each of the three developmental
outcomes for first instar larvae (L1) is shown: mortality as pupae, eclosion as non-viable adult, eclosion as functional (flying) adult. B) Dose response for four
tetracyclines. Proportion of L1 surviving to functional adult data is shown after rearing on various concentrations of each tetracycline. Solid lines indicate the
best-fit model; see also Table 2 for EC50 calculated from this model. Dashed vertical lines represent mean concentrations of each analogue (in the same
colour as the lines themselves) found in environmental bodies of water [15, 20, 36–40]. If reported values were below the limit of quantification (LOQ), the
LOQ value was used to populate the mean. Error bars represent the 95% confidence intervals.
doi:10.1371/journal.pntd.0003999.g002
Aedes aegyptiOX513A and Tetracycline
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Concentration of tetracyclines in environmental water samples
Sampling site selection. Water sampling points were selected based on the possible pres-
ence of tetracyclines in surface waters, or presence of Ae. aegypti larvae. Tetracyclines are
found in surface water bodies impacted by sewage input or veterinary activity, especially inten-
sive poultry and fish production. Considering this information, surface water samples were col-
lected from three different sewage impacted creeks in Campinas, São Paulo State, Brazil
(Pinheiros Creek, Anhumas Creek and Piçarrão Creek), one private fish production lake and a
stream located near a poultry CAFO (Concentrated Animal Feeding Operation). Water sam-
ples were also acquired from known Ae. aegypti breeding sites located in an industrial equip-
ment facility in Campinas. Samples were collected on 27th November 2013, in the rainy season.
Water was sampled from six different types of container, mainly refuse and discarded materials
(images in S1 Fig), all of which contained larvae at the time of sampling. In addition to these
environmental samples, rain water and tap water samples were collected in Campinas and in
Itu, São Paulo, Brazil. For all sampling points, 1 L water samples were collected in triplicate,
resulting in 45 samples. GPS coordinates for sampling points are provided in S3 Table.
Sampling procedure. The sampling of water was carried out using amber glass bottles (1
L) previously cleaned in the laboratory and rinsed with the sample water on site. The bottles
were wrapped in aluminum foil and transported on ice to the laboratory. All samples were
immediately submitted to extraction and clean up procedures.
Chemical analysis. Each sample was tested for the three tetracyclines most commonly
reported in the environment due to their extensive use in agriculture: tetracycline, oxytetracy-
cline and chlortetracycline.
Raw samples (1 L) were acidified to pH 3 using HCl, 500 mg of Na2EDTA were added and
samples were filtered through 0.45 μm cellulose acetate membranes. Tetracyclines were
extracted from water samples using a SPE procedure in a lab-made system [25]. OASIS HLB
cartridges (500 mg, Waters) were used as sorbent and were conditioned with 6 mL of methanol,
6 mL of deionized water and 6 mL of 0.5 g L-1 Na2EDTA solution (pH 3). After sample elution,
cartridges were dried under nitrogen flow for 20 minutes and tetracyclines were extracted
using 6 mL of methanol. Solvent was carefully evaporated to dryness with a gentle flow of
nitrogen and the target compounds were resuspended to a final volume of 1.0 mL in a 0.1% for-
mic acid solution in water:methanol, 90:10 (v/v).
Tetracycline compound determination was performed by LC-MS/MS (Agilent 6410) using
a Zorbax SB-C18 column (2.1 x 30 mm, 3.5 μm particle size) and deionized water (A) and
methanol (B) containing 0.1% formic acid as mobile phase solvents at a flow rate of 0.3 mL
min-1. The gradient composition was 10% B for 1 min, followed by an increase of B to 100% in
7 min. This composition was held for 1 min, when the initial conditions were re-established
and maintained for 5 min before the next analysis. Tetracyclines were ionized using an electro-
spray source (ESI) in positive mode. Ultrapure nitrogen (99.995%) was used as drying gas
(350°C at a flow rate of 10 L min-1) and in the collision cell. Nebulizer pressure was set at 55 psi
and a capillary voltage of 2000 V was used. Multiple reaction monitoring (MRM) parameters
for each of the tetracyclines are shown in S4 Table.
Effects of adult ingestion of chlortetracycline on their OX513A progeny
OX513A homozygous larvae were reared at<1 larvae mL-1 in the presence of 30 μg mL-1
chlortetracycline and WT larvae were reared in the absence of tetracycline. Adults were placed
into cages as follows; OX513A♂ crossed to WT♀ and OX513A♀ crossed to WT♂.
Adult cages were assigned to one of three chlortetracycline treatments; 50 μg mL-1 chlortet-
racycline sugar water and 50 μg mL-1 chlortetracycline blood meal, 100 μg mL-1
Aedes aegyptiOX513A and Tetracycline
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chlortetracycline sugar water and 100 μg mL-1 chlortetracycline blood meal, or chlortetracy-
cline free sugar water and chlortetracycline free blood meal (not performed for OX513A♀
crossed to WT♂) (Table 1). Each chlortetracycline treatment had three repeats for each adult
cross combination. Eggs were collected. Chlortetracycline concentrations were chosen to reflect
levels well above the maximum recorded plasma levels following a therapeutic treatment with
tetracyclines [26, 27].
The heterozygous progeny from each treatment were reared according to the insect rearing
method described above with six cohorts set for each group to assess the effect of parental
chlortetracycline ingestion. Raw data are presented in S5 Table.
Statistical analyses
Data were analysed using the RStudio software package version 0.97.318 (RStudio, USA). Nor-
mality of data was tested using the Shapiro-Wilk method.
Bioaccumulation of chlortetracycline in the biological materials was shown to be not nor-
mally distributed and therefore analysed using Wilcoxon Rank Sum.
Dose response data was analysed for significant differences between concentrations using
either a Student’s t-test if normally distributed or Wilcoxon Rank Sum if not normally distrib-
uted. The data was modelled using the Weibull model for chlortetracycline and a Log-linear
model for the remaining antibiotics. These models were used to calculate the EC50 (Effective
Concentration50) with 95% confidence intervals.
Chlortetracycline ingestion data were analysed using ANOVA for normally distributed data
or a Kruskal-Wallis test for non-normally distributed data. Post-hoc analysis was carried out
using the Nemenyi test, using the Coin and Multcomp R packages. For the on-tetracycline
reared controls, differences in functional adults were tested using the Wilcoxon Rank Sum test.
Results
Dose response of OX513A to tetracycline and its analogues
OX513A larvae reared at chlortetracycline concentrations at or below 1 ng mL-1 did not give
rise to a significantly greater percentage of functional adults than larvae reared in the absence
of tetracycline (0 μg mL-1) (t(18) = -1.36, p = 0.19). Functional adult numbers begin to deviate
from the baseline when reared at 3 ng mL-1 (t(13) = -3.49 p = 0.004), therefore concentrations
in excess of 1 ng mL-1 give rise to an increasing fraction of functional adults. Fig 2A shows the
percentage of functional adults increasing with greater chlortetracycline concentrations, with
Table 1. Experimental design of OX513A chlortetracycline ingestion. Parental crosses of OX513A homozygotes were crossed to wild type (WT). These
adults were provided with blood and sugar water supplemented with chlortetracycline (TC) at three concentrations; 0 μg mL-1, 50 μg mL-1 or 100 μg mL-1.
Progeny were reared in cohorts of 200 individuals in the presence or absence of chlortetracycline.
Parental cross Progeny
Group Description Male Female TC Blood and Sugar (μg mL-1) TC
A No TC control OX513A WT 0 NO
B Experimental OX513A WT 50 NO
C Experimental WT OX513A 50 NO
D Experimental OX513A WT 100 NO
E Experimental WT OX513A 100 NO
F Rearing control OX513A WT 0 YES
G Rearing control OX513A WT 50 YES
doi:10.1371/journal.pntd.0003999.t001
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the model predicting the maximum rescue plateau beginning to appear at 1 μg mL-1. This indi-
cates that concentrations at or slightly above 1 μg mL-1 will give rise to the maximum percent-
age of functional adults.
For the other tetracycline compounds tested, concentrations at or below 3 ng mL-1 tetracy-
cline, 10 ng mL-1 oxytetracycline and 0.1 ng mL-1 doxycycline, did not give rise to a signifi-
cantly greater portion of functional adults than if reared in the absence of tetracycline (Z = 6.5,
p = 0.48; Z = 3, p = 0.64; Z = 1.5, p = 0.27, respectively) (Fig 2B).
For all four tetracyclines, increasing tetracycline concentrations resulted in incremental
shifts towards increased survivorship of OX513A individuals (Fig 2A and 2B). With reference
to Fig 2A, as the chlortetracycline concentration increases to result in more functional adults
than 0 μg mL-1 tetracycline, the sample population shifts towards a higher survivorship with an
increasing fraction of non-viable adults and decreasing fraction of dead pupae. With further
increases in the chlortetracycline concentration, the non-viable adult fraction drops and the
population shifts to eclosing as functional adults. This demonstrates that increasing tetracy-
cline concentrations have incremental rescue effects on OX513A resulting in an average
increase in survivorship represented by an increased proportion of flying functional adults.
The EC50 values (half maximal effective concentration; the concentration which induces a
response halfway between the baseline and maximum) shown in Table 2, demonstrate that
doxycycline is the most effective analogue at rescuing the OX513A phenotype, being able to
rescue individuals at a lower concentration than the other tetracyclines.
Changes in chlortetracycline concentration during mass rearing
Quantification of the changes in chlortetracycline within OX513A over the duration of rearing
demonstrates that chlortetracycline is bio-accumulated to a concentration of 260 μg g-1eight
times greater than the concentration initially present in the rearing water (30 μg mL-1) (Fig 3).
The peak in bioaccumulation appeared at four days post hatching, when the larvae had reached
the third instar (L3). After this point, the concentration of chlortetracycline in the biological
samples decreased so that by the pupal stage there was no significant difference between the
concentration in the pupae compared to the eggs or L1 larvae, which is before exposure to tet-
racycline (Z = 29.5 p = 0.62). Samples of male and female pupae were analysed separately for
differences in bioaccumulation but no significant difference was found (t(8) = 0.16, p = 0.88);
combined data are therefore presented in Fig 3A.
The analysis of the associated larval rearing water indicates that the concentration of chlor-
tetracycline decreased rapidly over the first four days of rearing from the starting concentration
of 30 μg mL-1 to 8.4 μg mL-1 (Fig 3B). This decrease correlates with the bioaccumulation of the
chlortetracycline seen in the larvae, as well as some of the chlortetracycline likely being
degraded by hydrolysis and photolysis. The concentration in the rearing water continued to
decrease over the remaining rearing days until only 1.4 μg mL-1 remained by the initiation of
pupation. This is 21 times lower than the starting chlortetracycline concentration.
Table 2. EC50 of tetracycline and analogues at rescuing OX513A. Tetracycline and analogues were
added to the larval rearing water at various concentrations and the EC50 (half maximal effective concentra-
tion) modelled. 95% confidence intervals are shown in parenthesis. Results are for functional (flying) adults.
Compound EC50 ng mL
-1 (95% C.I.)
Oxytetracycline 113 (89 to 138)
Tetracycline 50 (34 to 66)
Chlortetracycline 13 (9 to 16)
Doxycycline 0.48 (0.40 to 0.60)
doi:10.1371/journal.pntd.0003999.t002
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Concentration of tetracyclines in environmental water samples
Water samples were collected from Ae. aegypti breeding sites to determine the environmental
concentrations of tetracyclines that OX513A larvae are likely to encounter in the field. Water
Fig 3. Life-stage analysis of the change in concentration of chlortetracycline.Chlortetracycline (TC) was added to the rearing water to a concentration
of 30 μg ml-1 one day post hatching, immediately after L1 / L2 sample was taken as indicated. At each sampling point, samples of the rearing water and
relevant insect life-stage (eggs/larvae (L1-L4)/pupae were collected. Tetracycline concentration was determined in A) OX513Amosquito larvae and pupae
and B) in the associated rearing water. Life-stage is indicated along with days post hatching (1–9). Error bars represent SEM.
doi:10.1371/journal.pntd.0003999.g003
Aedes aegyptiOX513A and Tetracycline
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sampling sites were selected based on their potential to contain high concentrations of tetracy-
clines (close to sewage plants or intensive livestock operations) or for being an Ae. aegypti larval
habitat, as determined by the presence of larvae. The concentration of each tetracycline tested;
tetracycline, oxytetracycline and chlortetracycline, was below the limit of quantification for
each of the field samples. The limit of detection was 1.0 pg mL-1 for tetracycline and chlortetra-
cycline and 2.5 pg mL-1 for oxytetracycline.
Effects of adult ingestion of chlortetracycline on their OX513A progeny
We investigated whether parental exposure to chlortetracycline could influence the survival of
heterozygous OX513A offspring. This might occur if tetracycline-fed females loaded tetracy-
cline in their eggs, for example. To provide maximal exposure to chlortetracycline, in all
experimental groups both blood and sugar water were supplemented with chlortetracycline to
50 μg mL-1 or 100 μg mL-1 (Table 1). No significant difference was observed between the prog-
eny of these groups (groups A to E) and those of the controls not provided with tetracycline
(group A) in terms of the fraction of dead pupae (F(4,25) = 2.44, p = 0.07), non-viable adults
(F(4,25) = 1.00 p = 0.43) or functional adults (H(4) = 9.93, p = 0.04, followed by Nemenyi
post-hoc analysis shows non-tetracycline-loaded control (A) vs experimental groups (B, C, D
and E) p =0.05.). Where larvae were provided with chlortetracycline, provision of chlortet-
racycline to the parents did not further increase survival (Z = 29, p = 0.09) (Fig 4, group F
compared to group G).
Fig 4. Phenotype of OX513A progeny from parents provided with tetracycline.OX513A adults crossed to wild type (WT) were provided with blood and
sugar water supplemented with chlortetracycline. Their progeny (data presented here) were reared in the presence (control) or absence of chlortetracycline
to determine the effect of parental ingestion of tetracycline. Error bars represent SEM. A to G represents groups in Table 1. Adult TC is the concentration of
chlortetracycline in the blood and sugar meals of the parents (μg mL-1). NT is no tetracycline administered. Progeny rearing TC is the concentration of
chlortetracycline added to the rearing water (μg mL-1).
doi:10.1371/journal.pntd.0003999.g004
Aedes aegyptiOX513A and Tetracycline
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Discussion
Owing to their use as human and veterinary therapeutics and prophylactics, tetracyclines are
known to be present in the environment, albeit at low levels as they are subject to photolysis,
hydrolysis and adsorption [11, 12]. In the absence of tetracycline, the tTAV gene in the strain
OX513A leads to a self-limiting phenotype, which can be rescued to near-normal viability by
sufficient levels of a suitable tetracycline [4]. For OX513A to be used as an effective vector con-
trol tool, it is important to understand the concentrations of tetracyclines which will allow an
increase in survival of OX513A relative to tetracycline-free conditions, and the possibility, if
any, of exposure of Ae. aegypti to such concentrations in the field.
Given that tetracyclines could be present in the environments where OX513A is used to
supress wild Ae. aegypti populations, it is important to know the lowest concentrations of tetra-
cyclines that would allow a greater than nominal fraction of functional adults to survive, as well
as understanding the consequences if larvae were to encounter tetracyclines in the environment
in terms of the numbers of potential functional females expected to emerge. This will help to
inform on the efficiency and speed of suppression of the Ae. aegypti population. Models indi-
cate that to have a significant impact on programme effectiveness, average OX513A heterozy-
gote fitness would have to increase to about 10% of WT, which would be equivalent to 10%
survival of L1s to functional adults, assuming such adults were fully fit [4]. We tested the effects
of four tetracyclines reported to be found in the environment from their use in human therapy
or agriculture on larval survival. We found that concentrations at or below 3 ng mL-1 tetracy-
cline, 1 ng mL-1 chlortetracycline, 10 ng mL-1 oxytetracycline and 0.1 ng mL-1 doxycycline gave
no significant increase in the survivorship of OX513A larvae, i.e. did not increase the propor-
tion of functional adults. Full rescue of the OX513A individuals (the maximum number surviv-
ing to functional adults) was also shown in this data to require tetracycline compound
concentrations that were 746 to 2500 times greater than the highest concentrations we found
reported in the literature for environmental tetracyclines.
In surveying the literature we found a few instances of reported environmental concentrations
of doxycycline above the concentration which would allow a greater than the nominal fraction of
OX513A larvae to develop to functional adults. However, such studies are often interested in the
impact of treatment and removal of antibiotics in waste-water treatment plants (e.g.[14, 20]) and
their associated rivers, and find the maximal tetracycline compound concentrations to be in the
sewage input to treatment plants. These environments are not the typical larval habitats of Ae.
aegypti. This species is a ‘container breeding mosquito’; its preferred breeding sites are refuse,
flower vases, water storage containers and other peri-domestic sites. Immature stages are found
in clean, still water, not flowing river systems and are rarely found in collections of water in the
ground such as earth drains [28–30]. Some reports have suggested that Ae. aegypti can breed in
septic tanks, usually where they are cracked or broken [22, 31], but this tends to be in the clear
water at the top of the tank whereas tetracyclines tend to bind to the sediments located at the bot-
tom of the tanks [16, 32] and are expected to represent a minority of breeding sites. As a conse-
quence of the lack of relevant field data, we undertook field sampling of actual Ae. aegypti larval
habitats and analysed the concentration of three tetracycline compounds. We found that for the
tetracyclines assessed, the concentration was below the level of detection, which was in turn
below the concentration necessary to allow any increase in survivorship of OX513A. Taken
together, these data indicate that levels of environmental tetracyclines are unlikely to lead to a
significant increase in the survival of the progeny of released OX513Amales.
For a suppression programme, OX513A males will be reared in a factory in the presence of
a tetracycline compound either in, or close to, the area of male release. It is therefore important
to understand how the mass production of OX513A males, which requires the use of
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tetracyclines, could affect the environmental concentrations of tetracyclines. Currently larvae
are mass reared in the presence of excess chlortetracycline (30 μg mL-1), but it was previously
unknown how much of the chlortetracycline the larvae accumulated over the course of devel-
opment and how much remained at the end of a rearing cycle. Here we have found that the
OX513A larvae bioaccumulate the chlortetracycline to over 8 times the initial starting concen-
tration. As a consequence of this process, and likely owing to some degree of photolysis and
hydrolysis, the concentration of chlortetracycline in the rearing water at the end of the rearing
cycle is 21 times lower than at the start. This is an important consideration in respect of poten-
tial effluent from mass rearing production. We estimate from these data that the spent water
from field rearing for an operational suppression programme, for example one aimed to treat a
human population of 10 million, would contain approximately 136 to 291 kg chlortetracycline
per annum. Putting this figure in context, it is estimated that the USA in 2011 used over 5 mil-
lion kg of tetracyclines in food-producing animals [33] and a further 113,832 kg in human
therapy [34]. Consequently the estimated waste chlortetracycline from the production of
OX513A males for a suppression programme constitutes a minute fraction of the total tetracy-
clines used in just one country.
Finally we investigated the hypothesis that the very small percentage of co-released OX513A
adult females [5] exposed to chlortetracycline in their diet could pass sufficient quantities through
their eggs to allow their progeny an increased level of survival. Tetracyclines are administered in
human therapy and as Ae. aegypti are highly anthropophilic, it could be envisaged that females,
after a blood meal from a human (or rarely an animal) taking a therapeutic course of tetracy-
clines, could ‘pre-load’ their progeny with enough tetracycline compound to allow an increase in
survival. In mammals the concentration of tetracycline compounds in the blood usually reaches a
peak 2 to 6 hours following an oral or injected dose, and then gradually declines due to the body’s
metabolic activity [26]. In both humans and livestock, the peak concentration of tetracyclines in
blood (plasma) following a standard therapeutic dose normally remains below 10 μg ml-1 [26,
27]. We found that feeding adult females 50 μg mL-1 or 100 μg mL-1 chlortetracycline in both
blood and sugar water did not lead to increased survival of their progeny. The highest dose of
chlortetracycline used in this study was 10-fold higher than the normal concentration found in
the blood of humans or animals receiving usual therapeutic doses of tetracyclines, and 5-fold
higher than the highest dose reported from any animal blood [27]. These data therefore disprove
the hypothesis that a female can deliver enough tetracycline to her progeny to allow increased sur-
vival rates through biting a human or animal on a normal therapeutic dose of tetracycline.
The results presented here analyse the interaction of tetracycline and its analogues with the
OX513A phenotype and explore different scenarios by which OX513A individuals may be
exposed to tetracyclines in the environment. Collectively, these data demonstrate that the low
levels of tetracycline or its analogues likely to be encountered in the environment will not
impact the efficacy or safety of using OX513A to control Ae. aegypti.
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